TipRanks
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market
CBIO
Crescent Biopharma
RESEARCH TOOLSreports
Want to see CBIO full AI Analyst Report?

Crescent Biopharma (CBIO) Balance Sheet

1,023 Followers

Crescent Biopharma Balance Sheet

Crescent Biopharma's total assets for Q2 2026 were $182.76M, a decrease of -8.22% from the previous quarter. CBIO total liabilities were $19.50M for the fiscal quarter, a 27.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 240.29M$ 35.62M$ 45.32M$ 51.81M$ 94.35M
Total Liabilities
$ 37.28M$ 51.10M$ 6.90M$ 8.88M$ 12.74M
Total Equity Gross Minority
$ 203.01M$ -15.48M$ 38.41M$ 42.93M$ 81.60M
Other Metrics
Currency in USD

Crescent Biopharma Debt to Assets